Footwear tends to be mass produced with variance among a specific style or type of footwear typically being limited to size. Mass production of footwear is facilitated by industrial processes, such as injection molding, that are effective in keeping costs down when many of the same item are made.
Footwear often lacks customizable features or features specific to an individual wearer or small group of wearers. The mass production technologies that keep costs low also tend to inhibit wearer-specific features.
A midsole may be injection molded with one shot of polyurethane (PU) foam or similar material. Such midsoles therefore tend to have homogenous material properties. If not homogenous, then the material properties are often unpredictable due to chaotic flow of injected material.
When molding an article of footwear, such as a shoe, a midsole may be customized by inserting a baffle into a midsole mold cavity to divide the cavity into sub-cavities. The sub-cavities may be injected with materials having different properties, which may be selected to provide an orthopedic function to the midsole. The baffle isolates the sub-cavities so that the different materials are precisely injected into the desired locations. The baffle remains in place and becomes part of the midsole. The material, thickness, and geometry of the baffle may be selected to provide further orthopedic function to the midsole. A stiffener may extend from the baffle, forwards or backwards along the length of the midsole or laterally, to provide further orthopedic function. The stiffener may include openings to promote bonding of injected material to the upper, outsole, or other part of the article of footwear.
The baffle allows for the orthopedic function provided by the different injected materials and the baffle itself to be customized for the specific individual wearer or a small group of wearers with similar orthopedic conditions.
The mold frame 102 defines a mold cavity 108. The mold frame 102 may include opposing side frames 110, 112 and a bottom frame 114. The mold frame 102 receives a last 116 that carries an upper 118 of an article of footwear that is under manufacture to enable the molding of a midsole onto the upper 118. The side frames 110, 112, bottom frame 114, and the last 116 may be movable with respect to each other to open and close the mold cavity 108. The opposing side frames 110, 112, bottom frame 114, and upper 118 as carried by the last 116 may be brought into mutual engagement to close the cavity 108. Material, such as polyurethane (PU), thermoplastic polyurethane (TPU), rubber, or the like, may be injected into the closed mold cavity 108 to form a midsole.
A baffle 104 is insertable into the mold cavity 108 to divide the mold cavity into a first sub-cavity 120 and a second sub-cavity 122. The baffle 104 isolates a first material injected into the first sub-cavity from a second material injected into the second sub-cavity. The second material has a differing material property to the first material. Examples of material properties include density, material composition (e.g., PU vs. TPU), color, and stiffness.
The baffle 104 may include a stiff piece of material that extends vertically in the mold cavity to act as a wall between the first sub-cavity 120 and the second sub-cavity 122. The baffle may be made of a suitable material such as plastic or metal. The baffle 104 may have a thin wall that is sufficiently strong and rigid to avoid significant deformation under pressure of injected material. While some deformation is tolerable, it should be understood that larger deformation may translate into less accuracy in the finished midsole.
The baffle 104 may include an injection opening 106 to receive an injection molding needle to inject a first material into the first sub-cavity 120. After injection of the first material into the first sub-cavity 120, the different second material may be injected into the second sub-cavity 122. The first and second materials bond to the upper 118 and outsole as well as to the baffle 104, which ultimately forms part of the finished article of footwear.
The baffle 104 allows a sequence of materials of different properties to be injected to make a customized midsole. A property, such as material composition, density, color, stiffness, and similar, may be varied at different locations of the midsole. This may be used to create a unique density profile, appearance, or similar feature for the article of footwear. Any number of material properties may be varied at any suitable location of a given midsole. The materials used may be selected to provide an orthopedic function to the midsole. For example, a stiffer material may be provided to the second sub-cavity 122 if the wearer has a heel strike gait, Conversely, a stiffer material ay be provided to the first sub-cavity 120 if the wearer has forefoot strike.
The baffle 104 may remain in the midsole after injection of the first and second materials to provide an orthopedic function to the midsole. As such, in addition to customizing the midsole by selection of the first and second injected materials, the characteristics of the baffle 104 may be selected as specific to the wearer or group of wearers. For example, the position, geometry, thickness, or material of the baffle 104 may be selected to provide a customized stiffness characteristic to the midsole.
The baffle 104 is inserted into the midsole mold cavity 108 to split the midsole mold cavity 108 into a first sub-cavity 120 and a second sub-cavity 122.
An injection needle 204 is inserted into the midsole mold cavity 108 and though an opening 106 in the baffle 104, so that a tip 206 of the injection needle 204 is positioned to inject material into the first sub-cavity 120. The injection needle 204 may be pushed through the opening 106, so that the tip 206 is inside the first sub-cavity 120. The opening 106 may be sized to tightly fit the injection needle 204, so that the baffle 104 seals against the injection needle 204 to prevent backflow of material from the first sub-cavity 120 to the second sub-cavity 122.
As shown in
As shown in
Then, as shown in
As shown in
Then, as shown in
The baffle article 300 includes a baffle 302 that extends vertically to isolate the sub-cavities from one another. The baffle 302 includes an opening 304 to receive an injection needle.
The baffle article 300 further includes an upper stiffener 306 extending from the baffle 302 to contact an upper of the article of footwear. The upper stiffener 306 remains with the baffle 302 in the midsole after injection of the midsole materials.
The upper stiffener 306 may provide an orthopedic function to the midsole. For example, the material, thickness, and geometry of the upper stiffener 306 may be selected based on a wearer's orthopedic needs.
The upper stiffener 306 may include bonding openings 308 to allow bonding of injected midsole material to the upper of the article of footwear. That is, material injected in the vicinity of the upper stiffener 306 may flow through the bonding openings 308 to contact the upper, so that the midsole and upper are bonded together in the vicinity of the upper stiffener 306.
The upper stiffener 306 may be shaped and sized to extend the full width and length sub-cavity. In other examples, the upper stiffener 306 is smaller than the sub-cavity.
The baffle article 300 further includes a lower stiffener 310 extending from the baffle 302 to contact an outsole of the article of footwear. The lower stiffener 310 remains with the baffle 302 in the midsole after injection of the midsole materials.
The lower stiffener 310 may provide an orthopedic function to the midsole. For example, the material, thickness, and geometry of the lower stiffener 310 may be selected based on a wearer's orthopedic needs.
The lower stiffener 310 may include bonding openings 312 to allow bonding of injected midsole material to the outsole of the article of footwear. Material injected in the vicinity of the lower stiffener 310 may flow through the bonding openings 312 to contact the outsole, so that the midsole and outsole are bonded together in the vicinity of the lower stiffener 310.
The lower stiffener 310 may be shaped and sized to extend the full width and length sub-cavity. In other examples, the lower stiffener 310 is smaller than the sub-cavity.
In some examples, the toe of the article of footwear points in a direction 320. Hence, the lower stiffener 310 is at the forefoot and the upper stiffener 306 is at the heel. In other examples, the toe of the article of footwear points opposite the direction 320, with the lower stiffener 310 being at the heel and the upper stiffener 306 being at the toe. The relative orientation of the stiffeners 306, 310 may be selected based on the orthopedic function provided.
The baffle article 400 includes a baffle 402 that extends vertically to isolate the sub-cavities from one another. The baffle 402 includes an opening 404 to receive an injection needle.
The baffle article 400 further includes a stiffener 406 extending from the baffle 402, The stiffener 406 may be designed to contact the upper or outsole of the toe region or heel region of the article of footwear. The stiffener 406 may provide an orthopedic function to the selected location of the midsole. Further, the stiffener 406 may include bonding openings 408 to allow bonding of injected midsole material to the upper or outsole of the article of footwear.
The baffle article 500 includes a plurality of baffles 502, 504. Each baffle 502, 504 extends vertically to isolate adjacent sub-cavities from one another. Each baffle 502, 504 includes an opening 506 to receive an injection needle.
The baffle article 500 further includes stiffeners 508, 510, 512. An end stiffener 508, 512 extends from a respective baffle 502, 504, A central stiffener 510 extends between the baffles 502, 504. Depending on the orientation of the baffle article 500 in the midsole, a stiffener 508, 510, 512 may contact the upper or outsole of the toe region, arch region, or heel region of the article of footwear. A stiffener 508, 510, 512 may provide an orthopedic function to its location in the midsole. Further, a stiffener 508, 510, 512 may include bonding openings 514 to allow bonding of injected midsole material to the upper or outsole of the article of footwear.
In other examples, any number of baffles and stiffeners may be provided. A baffle may isolate sub-cavities along a length of a midsole to provide a midsole orthopedic profile along the length of the article of footwear. A baffle may isolate sub-cavities along a width of a midsole to provide a midsole orthopedic profile along the width of the article of footwear.
At block 704, a baffle is inserted into a midsole mold cavity to separate the cavity into a plurality of sub-cavities. The baffle may include a stiffener. The baffle may be positioned in the cavity by a robot or human operator. An upper of the article of footwear may be provided to the mold cavity on, for example, a last. The mold cavity may then be closed.
At block 706, an injection needle is positioned to inject first material into a first midsole sub-cavity defined by the baffle. The injection needle may be pushed through an opening in the baffle.
At block 708, a first material is injected into the first sub-cavity to fill the first sub-cavity with first material. The first material may be selected to have a specific property, such as material composition, density, color, stiffness, or similar, that may be tailored to the specific article of footwear or the intended wearer.
At block 710, the same or a different injection needle is positioned to inject second material into a second midsole sub-cavity defined by the baffle. The injection needle may be retracted from the opening in the baffle, inserted through a different opening in the baffle, or inserted into the cavity from a different direction.
At block 712, a second material is injected into the second sub-cavity to fill the second sub-cavity with second material. The second material may be selected to have a specific property different from the first material, such as material composition, density, color, stiffness, or similar, that may be tailored to the specific article of footwear or the intended wearer.
The method 700 ends at block 714 with the formation of a midsole having an arrangement of materials of different properties and an integral baffle.
At block 804, data of a wearer's foot is captured. This may be done by a three-dimensional (3D) scan or other measurement technique to capture the shape of the foot, pressure plate analysis, gait analysis, or similar biometric measurement techniques. Such captured data may be used to determine the structure and composition of the midsole to be manufactured.
At block 806, a baffle is configured based on the data captured for the wearer's foot. An orthopedic analysis of an individual user of the footwear may be performed to select or configure the baffle. The shape, size, geometry, and material of the baffle, as well as any stiffeners provided to the baffle, may be selected as specific to the wearer. The number of zones of midsole material variance, may be selected as specific to the wearer. A baffle may be selected from a library of stock baffles. A baffle may be created on-demand, such as by 3D printing.
At block 808, a plurality of different midsole materials is selected. The materials may be selected for properties such as material composition, density, color, stiffness, and so on. The materials may be selected in conjunction with the baffle and any stiffeners provided to meet the orthopedic needs of the wearer. Hence, the midsole of the footwear may be customized to the wearer.
At block 810, the baffle is placed in a midsole mold cavity and then, at block 812, an injection needle is positioned to inject material into a sub-cavity defined by the baffle.
Material is injected into the sub-cavity, at block 814.
The same or different injection needle is positioned at another sub-cavity and the next selected material is injected, until the midsole is complete, at block 816.
The method ends at block 818 with the formation of a midsole having a customized arrangement of differing materials and an integrated baffle.
In view of the above, it should be apparent that the techniques described herein provide for readily customizable midsoles specific to a single wearer or group of wearers. Baffles may be used to define midsole sub-cavities for injection of materials of different properties to provide an orthopedic function. A baffle may include a stiffener to enhance the orthopedic function of the midsole.
It should be recognized that features and aspects of the various examples provided above can be combined into further examples that also fall within the scope of the present disclosure. In addition, the figures are not to scale and may have size and shape exaggerated for illustrative purposes.
Filing Document | Filing Date | Country | Kind |
---|---|---|---|
PCT/US2019/048186 | 8/26/2019 | WO |